^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ADCV01

    i
    Associations
    News

    Trials

    Company:
    Ever Supreme Bio Tech
    Drug class:
    T-lymphocyte cell therapy, Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients (NCT04115761)
    Phase 2
    Ever Supreme Bio Technology Co., Ltd.
    Recruiting
    Last update posted :
    03/23/2022
    Initiation :
    06/06/2019
    Primary completion :
    12/31/2022
    Completion :
    12/30/2023
    PD-L1 • IDH1 • CD8 • PD-1
    |
    IDH wild-type • PD-1-L
    |
    ADCV01